View Post

Breast cancer vaccine safely generates anti-tumor immunity

In In The News by Barbara Jacoby

By: Michael McCarthy. From: newsroom.uw.edu Study findings suggest that a vaccine could be used to prevent or treat a particularly aggressive form of breast cancer. An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the journal …

View Post

Breast-Conserving Surgery Safe for Deeply Seated Breast Cancer

In In The News by Barbara Jacoby

By: Deborah L. Ungerleider, MD From: medscape.com The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways When performing breast-conserving surgery, the retroglandular approach via incision in the inframammary fold for excision of a retroglandular tumor is feasible and safe. This incision gives better cosmetic results while allowing …

View Post

What to know about breast cancer and soy

In In The News by Barbara Jacoby

From: medicalnewstoday.com Soy is a type of legume that contains plant compounds called phytoestrogens. These compounds share similarities with the hormone estrogen, which plays a role in the development of certain breast cancers. For this reason, scientists have investigated whether soy may affect breast cancer development and progression. Breast cancer is the most commonTrusted Source cancer globally. Though treatment advances …

View Post

Large Analysis Confirms Safety of Nipple-Sparing Mastectomy

In In The News by Barbara Jacoby

By: Donavyn Coffey From: medscape.com A new analysis of over 22,000 mastectomy patients confirms what smaller studies have indicated: Patients who undergo nipple-sparing mastectomy have similar overall and disease-free survival to those who receive a total mastectomy. When nipple-sparing mastectomy was introduced, many experts felt uneasy about opting for the less invasive procedure, recalled Rosa Hwang, MD, associate medical director …

View Post

Junjie Li, MD, on Capecitabine in Triple-Negative Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Jeff Minerd From: medpagetoday.com Clinical trial focused exclusively on TNBC patients Current breast cancer treatment guidelines suggest that capecitabine (Xeloda) should be considered for adjuvant treatment after standard neoadjuvant therapy with taxane- and anthracycline-based chemotherapy. However, although randomized trials have evaluated capecitabine as adjuvant treatment in breast cancer overall as well as in elderly patients, none have focused solely …

View Post

Can Complementary Therapies Help Breast Cancer Patients?

In In The News by Barbara Jacoby

By: Plastic Surgeon and Breast Reconstruction Specialist Dr. Constance Chen From: prweb.com Breast cancer, the most commonly occurring cancer in women, is traditionally treated with a combination of surgery, radiation, and chemotherapy. In seeking to maximize the benefits of these treatments and minimize their often-debilitating side effects, many women consider adding various complementary therapies to their treatment regimens. “Complementary therapies …

View Post

Alteogen confirms safety, efficacy of HER2 breast cancer therapy

In Clinical Studies News by Barbara Jacoby

By: Shim Hyun-tai From: koreabiomed.com The American Society of Clinical Oncology (ASCO) is one of the most noteworthy events in the global biotech industry as it provides an opportunity to gauge the clinical success of pipelines for pharmaceuticals on the global stage. This is the sixth in a series of articles Korea Biomedical Review publishes to present the key clinical …

View Post

At-Home Gene Test for Breast, Ovarian Cancers Looks Effective

In In The News by Barbara Jacoby

By: Serena Gordon From: healthday.com Screening for breast and ovarian cancer genes might be added to the list of medical tests that can be safely and effectively done from home, new research suggests. The study looked at screening for BRCA1, BRCA2 and other gene mutations linked to an increased risk of breast and ovarian cancer. Women with a BRCA1 or …